25 May 2013
Keywords: Alnylam, EU patent, RNAi, oncology
Article | 10 September 2009
Alnylam Pharmaceuticals of the USA says that the European Patent Office (EPO) has issued a notification of intent to grant ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 September 2009
24 May 2013
© 2013 thepharmaletter.com